A novel therapeutic strategy for atherosclerosis: autophagy-dependent cholesterol efflux
Author:
Funder
the nature science foundation of heilongjiang province
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Biochemistry,Physiology
Link
https://link.springer.com/content/pdf/10.1007/s13105-021-00870-5.pdf
Reference112 articles.
1. Amengual J, Guo L, Strong A, Madrigal-Matute J, Wang H, Kaushik S et al (2018) Autophagy is required for sortilin-mediated degradation of apolipoprotein B100. Circ Res 122:568–582. https://doi.org/10.1161/CIRCRESAHA.117.311240
2. Avart SJ, Bernard DW, Jerome WG, Glick JM (1999) Cholesteryl ester hydrolysis in J774 macrophages occurs in the cytoplasm and lysosomes. J Lipid Res 40:405–414. https://doi.org/10.1016/S0022-2275(20)32444-5
3. Bi X, Vitali C, Cuchel M (2015) ABCA1 and inflammation. Arterioscler Thromb Vasc Biol 35:1551–1553. https://doi.org/10.1161/ATVBAHA.115.305547
4. Blom DJ, Raal FJ, Santos RD, Marais AD (2019) Lomitapide and mipomersen—inhibiting microsomal triglyceride transfer protein (MTP) and apoB100 synthesis. Curr Atheroscler Rep 21:48. https://doi.org/10.1007/s11883-019-0809-3
5. Brichkina A, Bulavin DV (2014) WIP-ing out atherosclerosis with autophagy. Autophagy 8:1545–1547. https://doi.org/10.4161/auto.21402
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeted treatment of atherosclerosis with protein–polysaccharide nanoemulsion co-loaded with photosensitiser and upconversion nanoparticles;Journal of Drug Targeting;2023-11-23
2. AMPK activators suppress cholesterol accumulation in macrophages via suppression of the mTOR pathway;Experimental Cell Research;2023-11
3. Recent Recent Advances: From Cell Biology to Cell Therapy in Atherosclerosis Plaque via Stent Implantation: From Cell Biology to Cell Therapy in Atherosclerosis Plaque via Stent Implantation;Current Medicinal Chemistry;2023-09
4. Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies;Pharmaceuticals;2022-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3